Next Financial Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-48
| Closed | -$8K | – | 2868 |
|
|
2021
Q2 | $8K | Buy |
48
+46
| +2,300% | +$7.67K | ﹤0.01% | 2085 |
|
|
2021
Q1 | $0 | Sell |
2
-2
| -50% | – | ﹤0.01% | 2680 |
|
|
2020
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 2332 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2236 |
|
|
2020
Q2 | – | Sell |
-181
| Closed | -$16K | – | 2105 |
|
|
2020
Q1 | $16K | Sell |
181
-245
| -58% | -$21.7K | ﹤0.01% | 1376 |
|
|
2019
Q4 | $46K | Hold |
426
| – | – | ﹤0.01% | 1224 |
|
|
2019
Q3 | $42K | Buy |
426
+150
| +54% | +$14.8K | ﹤0.01% | 1197 |
|
|
2019
Q2 | $36K | Buy |
+276
| New | +$36K | ﹤0.01% | 1277 |
|
|
2018
Q4 | – | Sell |
-190
| Closed | -$26K | – | 2157 |
|
|
2018
Q3 | $26K | Buy |
+190
| New | +$26K | 0.01% | 712 |
|
|
2017
Q4 | – | Sell |
-240
| Closed | -$34K | – | 1569 |
|
|
2017
Q3 | $34K | Hold |
240
| – | – | 0.01% | 827 |
|
|
2017
Q2 | $29K | Hold |
240
| – | – | 0.01% | 957 |
|
|
2017
Q1 | $31K | Sell |
240
-98
| -29% | -$12.7K | 0.01% | 898 |
|
|
2016
Q4 | $41K | Sell |
338
-1,185
| -78% | -$144K | 0.01% | 1050 |
|
|
2016
Q3 | $187K | Buy |
1,523
+417
| +38% | +$51.2K | 0.03% | 485 |
|
|
2016
Q2 | $129K | Buy |
1,106
+440
| +66% | +$51.3K | 0.04% | 397 |
|
|
2016
Q1 | $92K | Buy |
666
+205
| +44% | +$28.3K | 0.03% | 448 |
|
|
2015
Q4 | $87K | Buy |
461
+71
| +18% | +$13.4K | 0.03% | 462 |
|
|
2015
Q3 | $60K | Hold |
390
| – | – | 0.02% | 580 |
|
|
2015
Q2 | $70K | Hold |
390
| – | – | 0.02% | 573 |
|
|
2015
Q1 | $67K | Hold |
390
| – | – | 0.02% | 584 |
|
|
2014
Q4 | $72K | Hold |
390
| – | – | 0.02% | 545 |
|
|
2014
Q3 | $65K | Hold |
390
| – | – | 0.01% | 828 |
|
|
2014
Q2 | $62K | Buy |
+390
| New | +$62K | 0.03% | 310 |
|